Calpro

In Vitro Diagnostics for Inflammatory Bowel Disease (Calprotectin Testing)calpro.no

Company typePrivate
Founded1993
HeadquartersLysaker, Norway
Headcount1–10
GTM typeB2B
OfferingHardware or Manufacturing

Calpro firmographics

Firmographics

Name: Calpro
Legal name: Calpro AS
Website: https://calpro.no
Company type: Private
Founded year: 1993
Operating status: Operating
Headcount range: 1–10 employees
Ownership category
akta.pro rank

Calpro industry classification

Industry

Product category: In Vitro Diagnostics for Inflammatory Bowel Disease (Calprotectin Testing)
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
SIC: In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry: Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
akta.pro secondary industry: Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

Calprotectin diagnostics
IBD monitoring tests
Inflammatory bowel disease
Lateral flow immunoassay
Laboratory ELISA kits

Where Calpro is headquartered

Location

Headquarters

HQ city: Lysaker
HQ country: Norway
HQ region: Europe

Offices3 records

Markets served

Calpro business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

Diagnostic Test Kits and Laboratory Assays: Sale of CalproSmart rapid test kits (Self-Test, Office, RUO variants) and CalproLab ELISA assay kits (ALP and HRP formats, including RUO versions). Products are sold as complete kits including all required components. One-time purchase model per kit/order. Distribution via direct sales (UK) and regional distributors (Europe, Middle East, Africa, Asia-Pacific).
Easy Extract Extraction Devices: Sale of Calpro Easy Extract prefilled extraction devices. Consumable product supporting the calprotectin testing workflow. Sold as 50-unit packs. Complements ELISA kit sales and supports home sampling workflows.
CalproSmart Digital Services and Integration: CalproSmart app-based monitoring service with secure cloud backend. API and DeepLink integration services for HIS/LIMS connectivity. Clinic portal for device and patient management. Revenue derived from connected testing ecosystem supporting the device kit sales.
Distribution Partnerships: Partnership with pharmaceutical companies requiring robust calprotectin biomarker tools for clinical trials and research. Sale of RUO (Research Use Only) products for pharmaceutical partner biomarker programs and clinical study deployments.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Calpro product offering

Product offering

Core offering

Calpro develops, manufactures, and distributes CE/IVD-marked calprotectin diagnostic test kits and a connected digital ecosystem for inflammatory bowel disease (IBD). The portfolio includes laboratory ELISA kits (CalproLab ALP and HRP), point-of-care rapid tests (CalproSmart Office), home self-tests (CalproSmart Self-Test), research-use-only variants, a prefilled stool extraction device (Calpro Easy Extract), and the CalproSmart digital platform (app, cloud backend, API, and DeepLink integration to HIS/LIMS). Products deliver quantitative fecal calprotectin results in under 20 minutes across the full IBD care pathway.

Product overview

Calpro offers a comprehensive portfolio of calprotectin-based diagnostic solutions spanning from laboratory ELISA assays to point-of-care and home monitoring. The portfolio includes CalproSmart Self-Test for patient home monitoring with smartphone app connectivity, CalproSmart Office for rapid point-of-care testing, CalproSmart RUO for research applications, CalproLab ELISA kits (ALP and HRP variants) for high-precision laboratory testing, CalproLab ELISA RUO for research use, and Calpro Easy Extract sample preparation devices. The ecosystem is unified through CalproSmart Services providing API and DeepLink integration connecting patient self-test data to clinical systems and enabling remote monitoring workflows.

Differentiator

Problem solved

Functional benefit

Brands

CalproSmart: App-guided lateral flow self-test for remote monitoring of patients with chronic inflammatory bowel disease (IBD), including Ulcerative Colitis and Crohn's disease. Includes Self-Test, Office, and RUO variants.
CalproLab
Easy Extract

Products and services

CalproSmart Self-Test (CAL201, CAL230, CAL240, CAL250) App-guided lateral flow self-test for remote monitoring of patients with chronic inflammatory bowel disease (Ulcerative Colitis and Crohn's disease). Enables patients to test at home and securely share quantitative fecal calprotectin results (77–1500 mg/kg) with their clinical team via smartphone app, supporting proactive flare detection. CE/IVD marked.
CalproSmart Office (CAL220)

Quantifiable outcome

94% sensitivity for CalproSmart Self-Test vs. laboratory ELISA
+5 more outcomes

Companies that use Calpro

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Calpro technology and API

Technology

Technology focussed Yes

API detail

Has API: Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Calpro partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

Creonate (UK)coreTechnology or Integration · 1 January 2025Creonate, a UK-based lateral flow manufacturer, merged with Calpro in 2025. Creonate operates one of Europe's largest lateral flow facilities with capacity of 2 million tests per day. The merger brought significant manufacturing scale and created the combined EkteDx family, strengthening Calpro's global production capabilities and innovation pipeline.
EkteDxcoreStrategic or Co-development Partner · 1 January 2025EkteDx is the parent company formed by the merger of Calpro and Creonate in 2025. The EkteDx family combines discovery, production, and commercialization to ensure supply security and rapid innovation in precision diagnostics. EkteDx operates from Bedford Technology Park, UK, and supports Calpro's international operations.
Svar Life Science GroupcoreStrategic or Co-development Partner · 1 January 2017Calpro became part of Svar Life Science Group in 2017, strengthening global presence and research capabilities. Svar Life Science's Malmö (Sweden) facility specializes in immunoassay and diagnostic technology supporting advanced clinical and research applications. The group relationship provides cross-functional research and commercial synergies.
TrioLab OYminorChannel Partner/ Reseller/ DistributorRegional distributor covering Finland and the Baltic states for Calpro's calprotectin diagnostic products.
SelinionminorChannel Partner/ Reseller/ DistributorRegional distributor covering Benelux for Calpro's calprotectin diagnostic products.
Menarini (Spain)minorChannel Partner/ Reseller/ DistributorRegional distributor covering Spain for Calpro's calprotectin diagnostic products.
Hibernian Medical (Ireland)minorChannel Partner/ Reseller/ DistributorRegional distributor covering Ireland for Calpro's calprotectin diagnostic products.
Tanigen (Czech Republic)minorChannel Partner/ Reseller/ DistributorRegional distributor covering Czech Republic for Calpro's calprotectin diagnostic products.
ISCARE Clinic (Czech Republic)minorStrategic or Co-development PartnerHealthcare clinic using CalproSmart Self-Test as part of a telemedicine platform for remote IBD monitoring. Remote care using CalproSmart achieved public health insurance reimbursement in Czech Republic from 2022, serving as a landmark case study demonstrating clinical and economic value of remote calprotectin monitoring.
Global Pharmaceutical PartnersminorChannel Partner/ Reseller/ DistributorCalpro supplies calprotectin biomarker tools to pharmaceutical companies requiring robust diagnostic tools for clinical trials, drug development, and biomarker programs. Products used include CalproLab RUO kits for research and CalproSmart RUO for remote patient monitoring in clinical studies.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Calpro competitors and assessment

Company assessment

Direct peers

R-Biopharm: German IVD manufacturer with a calprotectin (CALEX/RIDASCREEN calprotectin) ELISA and extraction device portfolio. Directly overlaps CalproLab ELISA and Easy Extract on the laboratory workflow, serving the same hospital and reference lab customers across Europe.
Eagle Biosciences: US IVD developer/distributor offering calprotectin and other gastroenterology biomarker assays. Competes with CalproLab and CalproSmart in North American research and clinical lab channels, often through OEM/distribution partnerships.
Bühlmann Laboratories: Swiss specialist and the dominant incumbent in fecal calprotectin testing, offering both laboratory ELISA (EK-CAL) and point-of-care/rapid calprotectin assays. Directly competes with CalproLab ELISA and CalproSmart on the same biomarker, customer base (gastroenterology labs and clinics), and clinical guidelines.
AESKU.Diagnostics: German IVD manufacturer with an inflammation and gastroenterology ELISA menu including calprotectin assays. Competes with CalproLab in European hospital and reference lab channels and shares a distributor-driven go-to-market model.
EKF Diagnostics: Wales-based diagnostics group with a QuikRead fecal calprotectin point-of-care product and related IVD menu. Competes with CalproSmart Office in clinic/POC settings and shares the same gastroenterology and primary care buyer base.
ALPCO Diagnostics: US-based IVD developer with a focused fecal calprotectin ELISA portfolio targeting gastroenterology research and clinical labs. Competes head-to-head with CalproLab ELISA in the US and offers a comparable single-biomarker value proposition for IBD differentiation and monitoring.
SENTINEL Diagnostics: Italian IVD manufacturer with a calprotectin ELISA and broader inflammatory/autoimmune menu. Competes with CalproLab ELISA in European hospital labs and shares distributor-led GTM motion in Southern Europe.
Demeditec Diagnostics: German IVD distributor and manufacturer with a calprotectin ELISA portfolio. Overlaps CalproLab ELISA in the European laboratory channel, particularly Germany and DACH, and operates a comparable distributor-driven commercial model.
Epitope Diagnostics: US-based ELISA kit manufacturer with a fecal calprotectin assay (KT-849) and adjacent IBD biomarker menu. Competes with CalproLab ELISA in research and clinical labs, particularly in North America and APAC.

Broad incumbents

ORGENTEC Diagnostika: German specialty IVD company (part of the Sebia/Aarebus group historically) with a broad autoimmune and inflammation menu including calprotectin assays. Competes with Calpro in the laboratory segment but serves a much wider biomarker portfolio across hospital labs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Calpro compliance and trust

Trust signal

Compliance3 records

Calpro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calpro leadership team

Management profile

Number of profiles

Profiles4 records

Calpro subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Calpro funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calpro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calpro

What does Calpro do?

Is Calpro a public or private company?

Calpro is a private company. It is classified as corporate owned and is currently operating.

When was Calpro founded?

Calpro was founded in 1993. It employs 1 to 10 people.

Where is Calpro based?

Calpro is headquartered in Lysaker, Norway, in the Europe region.

How does Calpro make money?

Four revenue lines are on record. Diagnostic Test Kits and Laboratory Assays are the primary driver. The others are easy Extract Extraction Devices, calproSmart Digital Services and Integration and distribution Partnerships.

Who are Calpro's main competitors?

Direct peers on record are R-Biopharm, Eagle Biosciences, Bühlmann Laboratories, AESKU.Diagnostics, EKF Diagnostics, ALPCO Diagnostics, SENTINEL Diagnostics, Demeditec Diagnostics and Epitope Diagnostics. ORGENTEC Diagnostika is listed as a broad incumbent.

Does Calpro have an API?

Yes. Secure API integration connecting CalproSmart data to Hospital Information Systems (HIS) and Laboratory Information Management Systems (LIMS) platforms. Enables automatic data transfer, real-time insights in existing systems, and streamlined clinician workflows. Alternative DeepLink integration allows app-in-app embedding within third-party applications for unified user experience without duplicate data storage. Developer documentation is at calpro.no/calprosmart-services.

What industry is Calpro in?

Calpro's product category is In Vitro Diagnostics for Inflammatory Bowel Disease (Calprotectin Testing). Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.